Literature DB >> 6497930

The use of polymorphic DNA and protein markers for the third complement component for determining linkage of familial hypercholesterolaemia.

S E Humphries, J A Donald, J J McFadden, S Shull, R Williamson, N I Jowett, D J Galton, J O Julsrud, K Berg, A Heiberg.   

Abstract

We have used DNA and protein polymorphisms for the third complement component (C3) to assess the potential of DNA markers in the diagnosis and study of familial hypercholesterolaemia (FH), and to confirm the reported linkage between FH and C3. The inheritance of FH and the C3 gene has been studied in 10 families by combining information from both the protein and DNA polymorphisms. Our results confirm that the C3 gene is loosely linked to the gene causing FH (lod score maximum of 2.0) at a recombination distance of 0.15. When these results are combined with previously published data the overall lod score maximum is 4.75 at a recombination distance of 0.2, meaning that the two genes will be inherited together in only about 80% of children. These results confirm that the gene that causes familial hypercholesterolaemia is linked to C3 and is therefore on chromosome 19, but C3 is not close enough to be used as a diagnostic marker.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497930     DOI: 10.1016/0021-9150(84)90056-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus.

Authors:  R Taylor; M Jeenah; M Seed; S Humphries
Journal:  J Med Genet       Date:  1988-10       Impact factor: 6.318

2.  Six DNA polymorphisms in the low density lipoprotein receptor gene: their genetic relationship and an example of their use for identifying affected relatives of patients with familial hypercholesterolaemia.

Authors:  S Humphries; L King-Underwood; V Gudnason; M Seed; S Delattre; V Clavey; J C Fruchart
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

3.  Linkage relationships of the gene for apolipoprotein CII with loci on chromosome 19.

Authors:  J A Donald; S C Wallis; A Kessling; P Tippett; E B Robson; S Ball; K E Davies; P Scambler; K Berg; A Heiberg
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia.

Authors:  B Horsthemke; A M Kessling; M Seed; V Wynn; R Williamson; S E Humphries
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI.

Authors:  A J Lusis; C Heinzmann; R S Sparkes; J Scott; T J Knott; R Geller; M C Sparkes; T Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Identification of deletions in the human low density lipoprotein receptor gene.

Authors:  B Horsthemke; A Dunning; S Humphries
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.